Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
132 studies found for:    hepatitis c phase 2 | Open Studies
Show Display Options
Rank Status Study
1 Unknown  Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy
Conditions: Hepatitis C;   Hepatitis B
Intervention: Drug: Pegasys; Copegus.
2 Unknown  CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects
Condition: Chronic Hepatitis C
Interventions: Drug: ChronVac-C + SOC;   Drug: SOC
3 Recruiting Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Interferon Deficiency
Intervention: Drug: interferon alpha 2b
4 Recruiting An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant
Condition: Hepatitits C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir;   Drug: Ribavirin
5 Recruiting A Study to Evaluate Chronic Hepatitis C Infection in Adult Liver Transplant Recipients
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: ribavirin (RBV)
6 Recruiting An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Sofosbuvir
7 Not yet recruiting A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants With Advanced Liver Disease
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir
8 Not yet recruiting Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection
Condition: Chronic Hepatitis C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir
9 Not yet recruiting An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection
Condition: Hepatitis C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir
10 Not yet recruiting Surveillance and Treatment of Prisoners With Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Sofosbuvir and ribavirin
11 Not yet recruiting A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV
Condition: Chronic Hepatitis C
Interventions: Drug: Victrelis® (boceprevir) 800mg by mouth, TID (200 mg tablets);   Drug: Peg-Intron® (peginterferon-α-2b), 1.5ug/kg sc injection;   Drug: Rebetol® (ribavirin), 1000/1200mg by mouth daily
12 Recruiting Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF;   Drug: RBV;   Drug: SOF oral granule
13 Unknown  Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients
Condition: Hepatitis C
Intervention: Drug: ribavirin pre-treatment
14 Recruiting Control and Eradication Within Australia of Hepatitis C From People Living With HIV
Conditions: Hepatitis C;   HIV;   HIV-HCV Coinfection
Intervention: Drug: Sofosbuvir and ribavirin
15 Recruiting Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination in Adolescents and Children With Chronic HCV-Infection
Condition: Hepatitis C Virus Infection
Intervention: Drug: LDV/SOF
16 Not yet recruiting Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection
Condition: Hepatitis C
Intervention: Other: On Plan
17 Unknown  A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Celgosivir;   Drug: Peginterferon alfa 2b + ribavirin
18 Recruiting Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)
Condition: Chronic Hepatitis C
Interventions: Drug: Grazoprevir;   Drug: Elbasvir
19 Recruiting Pharmacokinetics, Pharmacodynamics and Safety of DEB025/Alisporivir in Combination With Ribavirin Therapy in Chronic Hepatitis C Genotype 2 and 3 Patients Who Have Previously Failed Interferon Therapy or Are Intolerant or Unable to Take Interferon
Condition: Hepatitis C, Liver Disease
Intervention: Drug: DEB025 and RBV
20 Recruiting Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C
Condition: Hepatitis C Infection
Interventions: Biological: MBL-HCV1;   Drug: Telaprevir (Part 1);   Drug: Sofosbuvir (Part 2)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years